Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
World
Jasmine Fernández

Two weight-loss drugmakers in legal battle over which is most effective in helping users shed pounds

Danish drugmaker Novo Nordisk filed a lawsuit against U.S. competitor Eli Lilly in a New Jersey federal court on Tuesday, alleging that the company engaged in false advertising regarding the effectiveness of its weight-loss treatments.

The suit accuses Indianapolis-based Eli Lilly of violating federal and state laws through nationwide promotional campaigns for its obesity drug Zepbound and diabetes drug Mounjaro.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.